Myanmar vs Tajikistan: Cause of death, by non-communicable diseases, ages 5-14, male
Myanmar
24.4%
in 2021
Tajikistan
24.0%
in 2021
Myanmar rank
130th
Tajikistan rank
132nd
Cause of death, by non-communicable diseases, ages 5-14, male over time
- Myanmar
- Tajikistan
How they compare
Myanmar currently reports 24.4% against 24.0% in Tajikistan, a difference of 0.4%.
The two have swapped places 2 times across 6 shared years of data; in 2000 it was Myanmar ahead.
Myanmar ranks 130th and Tajikistan ranks 132nd of 185 countries.
Myanmar has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Myanmar | Tajikistan | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 19.1% | 19.1% | 0.1% | Myanmar |
| 2010s | 24.3% | 23.6% | 0.7% | Myanmar |
| 2020s | 26.7% | 22.9% | 3.8% | Myanmar |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 5-14, male, Myanmar or Tajikistan?
- Myanmar, at 24.4% against 24.0% in Tajikistan as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 5-14, male between Myanmar and Tajikistan?
- 0.4%, with Myanmar ahead.
- How many years of comparable data are there for Myanmar and Tajikistan?
- 6 years are reported by both, from 2000 to 2021.
- How do Myanmar and Tajikistan rank globally for cause of death, by non-communicable diseases, ages 5-14, male?
- Myanmar ranks 130th and Tajikistan ranks 132nd of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 5-14, male (% of total male deaths ages 5-14). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of male deaths ages 5-14 due to non-communicable diseases divided by number of all male deaths ages 5-14, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.